Dynamics of drug response informs rational combination regimens.
Dynamics of drug response informs rational combination regimens.
Sci Signal. 2019 Aug 20;12(595):
Authors: Paudel BB, Quaranta V
Abstract
Metabolic plasticity in cancer has been linked to the development of drug-tolerant populations. In this issue of Science Signaling, Goldman et al integrate metabolic plasticity with phenotypic state transitions to examine how this reprogramming can be therapeutically exploited.
PMID: 31431544 [PubMed - in process]
Source: Science Signaling - Category: Biomedical Science Authors: Paudel BB, Quaranta V Tags: Sci Signal Source Type: research